Potential epigenetic mechanism in non-alcoholic Fatty liver disease

• Published in: International Journal of Molecular Sciences Vol. 16; no. 3; pp. 5161 - 5179
• Main Authors: Sun, Chao, Fan, Jian-Gao, Qiao, Liang
• Format: Journal Article Book Review
• Language: English
• Published: Switzerland MDPI AG 05.03.2015; MDPI
• Subjects: Animals; DNA Methylation; Epigenesis, Genetic; Epigenetics; Fatty acids; Hepatology; histone modifications; Histones - metabolism; Humans; Liver cirrhosis; Liver diseases; microRNA; MicroRNAs - metabolism; non-alcoholic fatty liver disease (NAFLD); Non-alcoholic Fatty Liver Disease - genetics; Non-alcoholic Fatty Liver Disease - metabolism; Non-alcoholic Fatty Liver Disease - pathology; non-alcoholic steatohepatitis (NASH); Review
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms16035161

Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive fat accumulation in the liver. It ranges from simple steatosis to its more aggressive form, non-alcoholic steatohepatitis (NASH), which may develop into hepatic fibrosis, cirrhosis, or hepatocellular carcinoma (HCC) if it persists for a long time. However, the exact pathogenesis of NAFLD and the related metabolic disorders remain unclear. Epigenetic changes are stable alterations that take place at the transcriptional level without altering the underlying DNA sequence. DNA methylation, histone modifications and microRNA are among the most common forms of epigenetic modification. Epigenetic alterations are involved in the regulation of hepatic lipid metabolism, insulin resistance, mitochondrial damage, oxidative stress response, and the release of inflammatory cytokines, all of which have been implicated in the development and progression of NAFLD. This review summarizes the current advances in the potential epigenetic mechanism of NAFLD. Elucidation of epigenetic factors may facilitate the identification of early diagnositic biomarkers and development of therapeutic strategies for NAFLD.